Lime Therapeutics
New York, US · Founded 2021 · 6 employees on LinkedIn · 2 known investors
Find your way into Lime Therapeutics
Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
Founders & leadership
Lime Therapeutics was founded in 2021 by Prakrit V. Jena.
PV
Prakrit V. JenainCo-founder & CTO
SS
Shardule ShahinCEOShardule Shah holds a PhD in immunology from Emory University and an MBA from Harvard Business School. As Co-founder and CEO of Lime Therapeutics, he leads the development of lipid-targeting therapeutics and previously led clinical studies at Roche Diagnostics and Lucira Health.
Investors · 2
In the news
Frequently asked questions
- What does Lime Therapeutics do?
- Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
- Who founded Lime Therapeutics?
- Lime Therapeutics was founded by Prakrit V. Jena in 2021.
- Who are Lime Therapeutics's investors?
- Lime Therapeutics's investors include HBS Angels of Boston, ZAKA VC.
- Where is Lime Therapeutics headquartered?
- Lime Therapeutics is headquartered in New York, US.